Even if one region reaches an equilibrium — be that of low or high disease and death — that might be disturbed when a new variant with new characteristics arrives.
The fact that immune systems have evolved to cope with constant infections, and the traces of viral genetic material embedded in our own genomes from ancient viral infections, are testament to such evolutionary battles.
Beyond Omicron: what’s next for COVID’s viral evolution.This is not the case: there is no predestined evolutionary outcome for a virus to become more benign, especially ones, such as SARS-CoV-2, in which most transmission happens before the virus causes severe disease.
Targets set for reduction should consider that circulating virus risks giving rise to new variants.
The more a virus replicates, the greater the chance that problematic variants will arise, most probably where spread is highest
New Haven, CT, United StatesNew York, NY, United StatesChicago, IL, United StatesChicago, IL, United States